Open AccessConversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter–Deficit Prodromal Cohort
Author(s) -
Danna Jennings,
Andrew Siderowf,
Matthew Stern,
John Seibyl,
Shirley Eberly,
David Oakes,
Kenneth Marek,
for the PARS Investigators
Publication year - 2017
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2017.0985
Subject(s) - hyposmia , cohort , dopamine transporter , medicine , population , parkinson's disease , rotterdam study , cohort study , disease , dopamine , infectious disease (medical specialty) , environmental health , dopaminergic , covid-19
Detecting individuals at risk for Parkinson disease (PD) during the prodromal phase could clarify disease mechanisms and allow for treatment earlier in the disease process to possibly slow or prevent the onset of motor PD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom